ESR1 and breast carcinoma: Evidence obtained in the present study suggests that zoledronic acid directly increased the activities of BKCa channels, and then activation of BKCa channel by zoledronic acid contributed to induce apoptosis in ER-negative MDA-MB-231 breast cancer cells.